Posted by linkadge on February 11, 2007, at 14:30:52
In reply to Re: GSK and Fabre-Kramer make agreement on Gepiron, posted by psychobot5000 on February 11, 2007, at 13:11:52
I was under the impression that gepirone had a much less d2 blocade (if any) as compared to buspar. I think it was also more potent at 5-ht1a than buspar, as well as well alpha-2 activity.
Linkadge
poster:linkadge
thread:731652
URL: http://www.dr-bob.org/babble/20070207/msgs/731833.html